Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.

× No keyword cloud information.

17 in total

Review 1. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Authors: G L Daikos; A Markogiannakis
Journal: Clin Microbiol Infect Date: 2011-06-02 Impact factor: 8.067

Review 2. Pharmacokinetic and pharmacodynamic evaluation of tigecycline.

Authors: Helen Giamarellou; Garyphallia Poulakou
Journal: Expert Opin Drug Metab Toxicol Date: 2011-09-30 Impact factor: 4.481

3. Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model.

Authors: G L Daikos; A Panagiotakopoulou; E Tzelepi; A Loli; L S Tzouvelekis; V Miriagou
Journal: Clin Microbiol Infect Date: 2007-02 Impact factor: 8.067

4. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.

Authors: Haejun Yim; Heungjeong Woo; Wonkeun Song; Min-Jeong Park; Hyun Soo Kim; Kyu Man Lee; Jun Hur; Man-Seung Park
Journal: Ann Clin Lab Sci Date: 2011 Impact factor: 1.256

Review 5. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis.

Authors: Efthimia Tasina; Anna-Bettina Haidich; Stamatia Kokkali; Malamatenia Arvanitidou
Journal: Lancet Infect Dis Date: 2011-07-23 Impact factor: 25.071

Review 6. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors: L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal: Clin Microbiol Rev Date: 2012-10 Impact factor: 26.132

Review 7. Combination therapy for carbapenem-resistant Gram-negative bacteria.

Authors: Alexandre P Zavascki; Jurgen B Bulitta; Cornelia B Landersdorfer
Journal: Expert Rev Anti Infect Ther Date: 2013-11-06 Impact factor: 5.091

Review 8. Combination therapy for carbapenem-resistant Gram-negative bacteria.

Authors: Mical Paul; Yehuda Carmeli; Emanuele Durante-Mangoni; Johan W Mouton; Evelina Tacconelli; Ursula Theuretzbacher; Cristina Mussini; Leonard Leibovici
Journal: J Antimicrob Chemother Date: 2014-05-28 Impact factor: 5.790

9. Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.

Authors: George Michail; Maria Labrou; Vassiliki Pitiriga; Styliani Manousaka; Nikolaos Sakellaridis; Athanasios Tsakris; Spyros Pournaras
Journal: Antimicrob Agents Chemother Date: 2013-09-23 Impact factor: 5.191

Review 10. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.

Authors: Matthew E Falagas; Panagiota Lourida; Panagiotis Poulikakos; Petros I Rafailidis; Giannoula S Tansarli
Journal: Antimicrob Agents Chemother Date: 2013-09-30 Impact factor: 5.191

1 in total

1. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae.

Authors: Wenxia Zhang; Yan Guo; Jiayin Li; Yiyuan Zhang; Yang Yang; Dong Dong; Demei Zhu; Ping He; Fupin Hu
Journal: Antimicrob Resist Infect Control Date: 2018-11-21 Impact factor: 4.887

1 in total